Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION AND NATURE OF BUSINESS (Details Narrative)

v3.24.1.1.u2
BASIS OF PRESENTATION AND NATURE OF BUSINESS (Details Narrative)
3 Months Ended
Mar. 31, 2024
USD ($)
Integer
U.S. Patents owned by the company 102
Expired patents 54
Foreign patents owned by the company 15
ILiAD Biotechnologies, LLC [Member]  
Aggregate investment amount | $ $ 7,000,000